首页> 美国卫生研究院文献>Biochemical Journal >Sulphation heterogeneity in the trisaccharide (GalNAcSbeta1 4GlcAbeta13GalNAcS) isolated from the non-reducing terminal of human aggrecan chondroitin sulphate.
【2h】

Sulphation heterogeneity in the trisaccharide (GalNAcSbeta1 4GlcAbeta13GalNAcS) isolated from the non-reducing terminal of human aggrecan chondroitin sulphate.

机译:从人类蛋白聚糖软骨素硫酸盐的非还原性末端分离出的三糖(GalNAcSbeta14GlcAbeta13GalNAcS)中的硫化异质性。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We report here the isolation and sulphation isomer analyses of trisaccharides GalNAcS(beta1,4)GlcA(beta1,3)GalNAcS (in which S indicates sulphate) derived from the non-reducing termini of aggrecan chondroitin sulphate. Rat chondrosarcoma and human aggrecans were digested for 1 h at 37 degrees C with 30 micro-units of endo-chondroitinase ABC per microgram of chondroitin sulphate, and trisaccharides were isolated from the digests by ToyoPearl HW40S gel-filtration chromatography. Four trisaccharide species were identified; their sulphation isomer compositions, as determined by digestion with chondroitinase ACII and fluorescence-based ion-exchange HPLC, were GalNAc4Sbeta1,4GlcAbeta1,3GalNAc4S, GalNAc4Sbeta1,4GlcAbeta1,3GalNAc6S, GalNAc4,6Sbeta1,4GlcAbeta1, 3GalNAc4S and GalNAc4,6Sbeta1,4GlcAbeta1,3GalNAc6S. The abundances of such sequences in chondroitin sulphate on aggrecan from normal (foetal to 72 years of age) and from osteoarthritic human knee cartilages were also established. The results showed that non-reducing terminal GalNAc4S or GalNAc4,6S can be linked to either a 4-sulphated or a 6-sulphated disaccharide, suggesting that the sulphation of the last disaccharide might not have a direct effect on the specificity of chondroitin sulphate terminal GalNAc sulphotransferases. Furthermore, for each aggrecan preparation examined, the 4S-to-6S ratio of all chain interior disaccharides was equivalent to that in the last repeating disaccharides at the non-reducing terminus, suggesting that neither chondroitin 4-sulphotransferase nor chondroitin 6-sulphotransferase shows preferential activity near the chain terminus.
机译:我们在这里报告的分离和硫酸盐异构体分析的三糖GalNAcS(beta1,4)GlcA(beta1,3)GalNAcS(其中S表示硫酸盐)衍生自聚集蛋白聚糖软骨素硫酸盐的非还原性末端。将大鼠软骨肉瘤和人聚集蛋白聚糖在37℃下用每微克硫酸软骨素30微单位的软骨素内切酶ABC消化1小时,并通过ToyoPearl HW40S凝胶过滤色谱法从消化物中分离出三糖。确定了四个三糖种类;通过软骨素酶ACII和基于荧光的离子交换HPLC消化确定的硫酸盐异构体组成分别为GalNAc4Sbeta1,4GlcAbeta1,3GalNAc4S,GalNAc4Sbeta1,4GlcAbeta1,3GalNAc6S,GalNAc4,6Sbeta1,4GlcAbeta1,3GalNAc4S4,4GlcAbeta1,3还确定了正常(胎儿至72岁)和骨关节炎的人膝软骨上聚集蛋白聚糖上硫酸软骨素中此类序列的丰度。结果表明,非还原性末端GalNAc4S或GalNAc4,6S可以与4或6硫酸化的二糖连接,这表明最后一个二糖的硫酸化可能不会直接影响硫酸软骨素末端的特异性。 GalNAc磺基转移酶。此外,对于所检查的每种聚集蛋白聚糖制剂,所有链内部二糖的4S与6S比率均与非还原末端最后一个重复的二糖的比率相等,这表明软骨素4-磺基转移酶和软骨素6-硫代转移酶均未显示优先链末端附近的活动。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号